Kiniksa Pharmaceuticals Ltd reports results for the quarter ended in January - Earnings Summary

Kiniksa Pharmaceuticals International

23/07/2024 15:21

* Kiniksa Pharmaceuticals Ltd  KNSA.OQ  reported a quarterly
adjusted loss of 6 cents​​ per share for the quarter ended in
January, lower than the same quarter last year, when the company
reported EPS of 21 cents.  The mean expectation of four analysts
for the quarter was for a loss of 7 cents per share. Wall Street
expected results to range from -12 cents tozero cents per share.
    * Revenue rose 44.7% to $103.39 million from a year ago;
analysts
expected $92.31 million. 
    * Kiniksa Pharmaceuticals Ltd's reported EPS for the quarter
was a
loss of 6 cents​.
    * The company reported a quarterly loss of $3.91 million.
    * Kiniksa Pharmaceuticals Ltd shares had risen by 14.6% this
quarter and gained 21.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 12.5%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Kiniksa
Pharmaceuticals Ltd is $32.00 
This summary was machine generated from LSEG data July 23 at
02:21 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.07          -0.06          Beat
 Mar. 31 2024      -0.16          -0.25          Missed
 Dec. 31 2023      -0.14          0.35           Beat
 Sep. 30 2023      -0.17          -0.20          Missed